JNJ-77242113 Shows Greater Efficacy Than Placebo for Plaque Psoriasis

Percentage of patients with PASI-75 response was higher with the interleukin-23-receptor antagonist peptide.

Related Keywords

Montreal ,Quebec ,Canada ,Robert Bissonnette ,Janssen Research ,Innovaderm Research ,Healthday News ,New England Journal ,Psoriasis Area ,Severity Index ,